Showing results (61-70 of 510) with videos related to
Sort By:
Pageof 51
Journal of Medical Genetics|July 25, 1998
The fragile X syndromeB B de Vries, D J Halley, B A Oostra, et al.Developmental Medicine and Child Neurology|August 18, 2001
Neonatal infarction within basal cerebral vein territoryP Govaert, R Swarte, A Oostra, et al.American Journal of Medical Genetics|April 1, 1992
Limited size of the fragile X site shown by fluorescence in situ hybridizationA J Verkerk, B H Eussen, J O Van Hemel, et al.Molecular and Cellular Biology|July 1, 1984
An antibody to a synthetic peptide recognizes polyomavirus middle-T antigen and reveals multiple in vitro tyrosine phosphorylation sitesR Harvey, B A Oostra, G J Belsham, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 21, 2004
Loss of FMR1 hypermethylation in somatic cell heterokaryonsVioleta Stoyanova, Stefano Rossetti, Leontine VAN Unen, et al.European Journal of Human Genetics : EJHG|March 3, 2005
Differential epigenetic modifications in the FMR1 gene of the fragile X syndrome after reactivating pharmacological treatmentsElisabetta Tabolacci, Roberta Pietrobono, Umberto Moscato, et al.Journal of Intellectual Disability Research : JIDR|February 1, 1994
The fragile-X syndrome: a growing gene causing familial intellectual disabilityL B De Vries, D J Halley, B A Oostra, et al.Journal of Molecular Histology|October 27, 2004
Prospects of TAT-mediated protein therapy for fragile X syndromeSurya A Reis, Rob Willemsen, Leontine van Unen, et al.Annals of Neurology|September 7, 2004
Homozygous PINK1 C-terminus mutation causing early-onset parkinsonismChristan F Rohé, Pasquale Montagna, Guido Breedveld, et al.Nature|August 4, 1983
Transforming activity of polyoma virus middle-T antigen probed by site-directed mutagenesisB A Oostra, R Harvey, B K Ely, et al.Pageof 51